Search results for #NTDT
Ready to grow your #hematology knowledge? #EHAMasterclass 2024-2025 applications are open - apply before June 30 to discover cases on: 🔎 Pediatric hematology 🔎 #Hemophilia 🔎 #Multiplemyeloma 🔎 #Lymphoma 🔎 #thalassemia and #NTDT Apply now: eha.fyi/MC_24/25 @young_eha
Attention #HCPs & interested individuals! Join our webinar on Feb. 2, exploring #TIF's guidelines on Non-Transfusion Dependent β-#Thalassaemia (#NTDT). Don't miss out on cutting-edge insights! ✅ 🔹Register at: bit.ly/47nr6X 🔹Full Agenda: bit.ly/47RiOaF
TIF's exclusive #webinar on Non-Transfusion Dependent β-#thalassaemia (#NTDT) Guidelines is coming up! 🗓️ Feb 2, 2024 / 15:00 CET 🌟 Featuring: Prof. Ali Taher, Prof. Maria D. Cappellini & Dr. Khaled Musallam 👉 Register: bit.ly/47nr6XH thalassaemia.org.cy/.../exclusive-…
#SaveTheDate - Mark your calendars for Feb. 2nd, 2024, as we present an exclusive #webinar on our Non-Transfusion Dependent β-#thalassaemia (#NTDT) Guidelines! Join & learn from international experts sharing crucial insights. Register: bit.ly/47nr6XH More info!🔜
Very interesting workshop on #NTDT at the Paed Haem Onc conference in Chennai. Amazing to see young ehtusiastic haematologists carrying the mantle for non-malignant haem in India #PHOCON2023
Dive into the new #ThalPals episode, exploring #TIF's groundbreaking #NTDT β-#thalassaemia #Guidelines! Join Dr @AEleftheriou156 & @drKMusallam for an eye-opening discussion on #thalassemia & future #drugdevelopments. 🎧 Listen now: pod.link/1639436269 @AgiosPharma
@MorphologyAmigo Yes indeed - just to confuse things genetic variance in HbF is normal and controlled by high F QTLs - this is the basis of some gene therapy treatments via BCL11A and also part of the reason why presentations so heterogenous in #SCD and #NTDT
The 3rd edition of #TIF's Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia (#NTDT) has arrived! Download and share the Guidelines at ⤵️ thalassaemia.org.cy/publications/t… #Thalassemia #Guidelines #Hematology #HCPs #Patients #New #Publication
Great news for patients with non-transfusion-dependent β-#thalassaemia (#NTDT) in the #EU! @bmsnews has secured complete marketing authorisation from the @EU_Commission for #Reblozyl (#luspatercept) to treat #anaemia in adult #patients with NTDT. bit.ly/3Zzzb8g
#TIFNews - Not 1 but 2 new publications of TIF's Guidelines for the Management of Non-Transfusion-Dependent Thalassaemia (#NTDT) are coming your way! ➡️ shorturl.at/kAOP5 #TIF #Publications #Thalassaemia #Thalassemia #Guidelines #Management #Patients #HCPs
Recent evidence + expert opinions on the detrimental consequences of untreated #anemia in pts with non-transfusion-dependent β-#thalassemia (#NTDT). How can clinicians, pharma, & agencies address critical unmet needs in this population? 👉bit.ly/3isjTBE @AliTaherMD
Mitapivat effective for Hemolytic Anemia in patients with non-transfusion dependent Thalassemia #mitapivat #Pyruvate-kinaseactivator #non-transfusiondependentα-thalassaemia #non-transfusiondependentβ-thalassaemia #NTDT medicaldialogues.in/medicine/news/…
➡️ Dr. Cappellini discusses current & emerging management approaches for patients with non-transfusion-dependent #thalassemia. #NTDT #OncTwitter #MedEd #CME 🖥️ ms.spr.ly/6014jgRXa